New Antibiotic Shows Promise in Fighting Drug-Resistant Gonorrhea
Neisseria gonorrhoeae, the bacteria responsible for the sexually transmitted infection gonorrhea, has developed resistance to many modern antibiotics. However, a recent study has identified a potential new class of antibiotic that could effectively combat these drug-resistant strains.
Researchers from the University of Konstanz in Germany and the University of Vienna in Austria have discovered a compound that triggers a self-destruct mechanism within N. gonorrhoeae, also known as gonococci.
The team investigated a group of alkyl quinolones (AQs), compounds that some bacteria use to activate attack and defense responses against other bacteria. By analyzing existing AQs and synthesizing new variations in the laboratory, they identified a molecule with unique capabilities.
Christof Hauck, a cell biologist at the University of Konstanz, explains that the compound 2-nonyl-4-quinolone N-oxide (NQNO), derived from Pseudomonas aeruginosa bacteria, demonstrated the ability to kill gonococci without harming other microorganisms or human cells.
NQNO disrupts the electron transport chain within gonococci, leading to increased stress on the bacteria and triggering the release of a toxin that causes self-destruction. Importantly, this compound does not harm beneficial bacteria present in the body.
Studies in mice models have shown the effectiveness of NQNO in treating gonorrhea, with researchers successfully enhancing its potency through chemical modifications.
Ann-Kathrin Mix, a microbiologist at the University of Konstanz, notes that N. gonorrhoeae poses a significant threat and is classified as a priority pathogen by the World Health Organization due to its ability to acquire genetic material from other microbes, including genes for antibiotic resistance.
While the development of this new antibiotic is still in its early stages, it presents a promising strategy to combat drug-resistant strains of N. gonorrhoeae.
Thomas Böttcher, a microbial biochemist at the University of Vienna, emphasizes the urgent need for new treatments as gonococci rapidly evolve resistance to existing antibiotics, rendering some strains untreatable.
The findings of this research have been published in Nature Microbiology, offering hope for a potential solution to the growing threat of drug-resistant gonorrhea.
